Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Challenges of Endocrine Therapy in Breast Cancer Publisher



Mansouri S1 ; Teymourzadeh A1 ; Farahmand L1 ; Majidzadeha K2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Recombinant Proteins Department, Motamed Cancer Institute, ACECR, Tehran, Iran
  2. 2. Genetics Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran

Source: Cancer Genetics and Psychotherapy Published:2017


Abstract

This chapter provides evidences on the magnitude of endocrine therapy in the treatment of breast cancer patients and also discusses challenges in endocrine therapy as well as reviewing recent literature on psychotherapy in the management of adverse effect of endocrine therapy. At first, there is a quick review on the role of estrogen in the breast cancer development which was followed by a brief data on the significance of endocrine therapy. Secondly, the major challenges in endocrine therapy such as non-adherent patients during the course of endocrine therapy, endocrine therapy failure especially Tamoxifen and Letrozole resistance and finally adverse effects of endocrine therapy will be discussed in the rest of chapter. Resistance to the endocrine therapy will be explained in details to elucidate the molecular mechanisms underlying this phenomenon. Finally, the recent evidences on the administration of psychotherapy to modulate the adverse effect of endocrine therapy briefly mentioned. © Springer International Publishing AG 2017. All rights reserved.
Other Related Docs